Paragraph IV Patent Challenges: Are You Prepared for Product Targeting?

Broadcast Date: Monday, March 23, 2015 from 3:00 pm to 5:00 pm (ET)
Consumer Law
Pablo D. Hendler
Dr. Richard A. Mortimer
Steven E. Feldman
Albert Jacobs


About Ropes & Gray LLP

When clients come to Ropes & Gray, they find a global team of more than 1,100 professionals, whose top-notch skills, varied backgrounds and unique perspectives can help them meet high-stakes challenges, solve complex problems and reach their goals. An international presence, the firm has offices in New York, Washington, D.C., Boston, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul.

Many of the world’s most respected companies and institutions are longtime clients. The firm serves many organizations (and investors and individuals) at all stages of the business life cycle, from start-ups to establishment as industry leaders.

Ropes & Gray has always focused on providing clients with the highest quality advice on their most critical legal and business needs. Ropes & Gray is a thoroughly contemporary firm that can bring 150 years of legal and institutional history to bear on the challenges clients face in today’s global, networked, 24/7 environment. A collaborative approach means that clients have ready access to leading corporate, litigation, transactional and regulatory lawyers whose knowledge and experience span industries and geographies.


About Analysis Group

Analysis Group’s more than 500 professionals provide economic, financial, and business strategy consulting to leading law firms, corporations, and government agencies. The firm’s 11 offices are located in Boston, Chicago, Dallas, Denver, Los Angeles, Menlo Park, New York, San Francisco, and Washington, DC; and internationally in Montreal and Beijing.


About Husch Blackwell LLP

Husch Blackwell has one of the premier Hatch-Waxman/generic drug patent litigation practices in the country.  We are experienced at developing first-filer and subsequent-filer strategies to get our clients’ generic products to market. We regularly prepare paragraph IV letters and assist clients in developing formulation and design around ANDA strategies. We also have experience in related FDA and regulatory litigation and counseling directed to obtaining marketing approval for generic drugs under the Hatch-Waxman Act. Cases of note involve the following drugs:   Norvasc®, Actonel®, Boniva®, Floxin® otic, Reclast®, Zometa®, Treanda®, Antara®, Uroxatral®, Eloxatin®, Ultracet®, Wellbutrin XL®, Strattera®, Intuniv®, Dexilant®, Lidoderm®, Megace ES®, Luvox CR®, Ambien CR®, Keppra XR®, Ryzolt®, Mirapex XR®, Requip XL®, Adderall XR®, Omnaris®, Benicar®, Aripiprazole OLSO®, Lotrel®, Clarinex®, Plavix®, Amrix®, Enablex®, and Cymbalta®.


About Albert Jacobs LLP

ALBERT JACOBS LLP is a full service IP firm providing patent protection on a global basis, litigation and appellate services and ITC representation for both plaintiffs and defendants. Opinions on infringement, validity and Freedom to Operate are provided not only in the Life Sciences but in a wide range of technologies including chemical, semiconductors and business methods as well as consumer products